Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Retinopathy of Prematurity

3,4-dihydroxyphenylacetic acid has been researched along with Retinopathy of Prematurity in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, N1
Favazza, TL1
Baglieri, AM1
Benador, IY1
Noonan, ER1
Fulton, AB1
Hansen, RM1
Iuvone, PM1
Akula, JD1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Retinopathy of Prematurity

ArticleYear
The rat with oxygen-induced retinopathy is myopic with low retinal dopamine.
    Investigative ophthalmology & visual science, 2013, Dec-19, Volume: 54, Issue:13

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Blotting, Western; Chromatography, High P

2013